Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?

被引:0
|
作者
O’Dane Brady
Scott Haldeman
机构
[1] World Spine Care,
[2] University of California,undefined
[3] University of California,undefined
关键词
Chiropractic; Spinal manipulative therapy; Spine palpation; Clinical decision making;
D O I
10.1186/2045-709X-21-35
中图分类号
学科分类号
摘要
The shared decision making process has become increasingly important in the management of spinal disorders where there remains a variety of treatment options. Spinal manipulative therapy (SMT) is often recommended as a conservative option by evidence based clinical practice guidelines and a treatment modality frequently utilized by chiropractors and other clinicians who offer SMT to their patients. This article serves as a commentary to a review of the methods that are often used by chiropractors to determine the site for applying their manipulative intervention. Though it may be easy to criticize any review of this type of literature and point out shortcomings there are strong take away messages for the clinician interested in employing SMT as a part of their treatment protocol. Most notably, clinicians can be reassured that a history on the localization of pain, tissue palpation, provocative testing, range of motion testing and the demonstration by the patient of the locus and description of pain have reasonable consistency between observers. What this paper does not inform us on is the nature of the lesion causing the pain or where the manipulation should be applied to obtain the best outcome.
引用
收藏
相关论文
共 50 条
  • [31] ANTITRUST RETROSPECTIVE AND PROSPECTIVE - WHERE ARE WE COMING FROM - WHERE ARE WE GOING
    FOX, EM
    SULLIVAN, LA
    [J]. NEW YORK UNIVERSITY LAW REVIEW, 1987, 62 (05) : 936 - 988
  • [32] Southeast Asia: Where We Have Been, Where We Can Go?
    Clymer, Kenton
    [J]. DIPLOMATIC HISTORY, 2021, 45 (02) : 223 - 239
  • [33] Endoscopic stenting-Where are we now and where can we go?
    Mark Terence McLoughlin
    Michael Francis Byrne
    [J]. World Journal of Gastroenterology, 2008, (24) : 3798 - 3803
  • [34] Treatment of depression in primary care -: Where we are, where we can go
    Katon, WJ
    Unützer, A
    Simon, G
    [J]. MEDICAL CARE, 2004, 42 (12) : 1153 - 1157
  • [35] Interventional radiology and the breast: where we are coming from and where we are going
    Tabanera, M. Torres
    [J]. RADIOLOGIA, 2010, 52 : 30 - 35
  • [36] Automatic web accessibility metrics: Where we are and where we can go
    Vigo, Markel
    Brajnik, Giorgio
    [J]. INTERACTING WITH COMPUTERS, 2011, 23 (02) : 137 - 155
  • [37] Immunotherapy for esophageal cancer: Where are we now and where can we go
    Shoji, Yoshiaki
    Koyanagi, Kazuo
    Kanamori, Kohei
    Tajima, Kohei
    Ogimi, Mika
    Ninomiya, Yamato
    Yamamoto, Miho
    Kazuno, Akihito
    Nabeshima, Kazuhito
    Nishi, Takayuki
    Mori, Masaki
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (19)
  • [38] Redrawing the Map to Novel DILI Biomarkers in Circulation: Where Are We, Where Should We Go, and How Can We Get There?
    Vazquez, Joel H.
    Mcgill, Mitchell R.
    [J]. LIVERS, 2021, 1 (04): : 286 - 293
  • [39] Postoperative Pain Management:Where are we now and where should we be going? Preface
    Joshi, Girish P.
    Bonnet, Francis
    [J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2019, 33 (03) : 257 - 258
  • [40] 'WHERE ARE WE, WHERE HAVE WE COME FROM, WHERE ARE WE GOING'
    BOLTON, K
    [J]. OVERLAND, 1991, (123): : 52 - 53